426 related articles for article (PubMed ID: 26043228)
1. GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
Iepsen EW; Lundgren JR; Hartmann B; Pedersen O; Hansen T; Jørgensen NR; Jensen JE; Holst JJ; Madsbad S; Torekov SS
J Clin Endocrinol Metab; 2015 Aug; 100(8):2909-17. PubMed ID: 26043228
[TBL] [Abstract][Full Text] [Related]
2. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.
Wadden TA; Hollander P; Klein S; Niswender K; Woo V; Hale PM; Aronne L;
Int J Obes (Lond); 2013 Nov; 37(11):1443-51. PubMed ID: 23812094
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.
Iepsen EW; Lundgren J; Dirksen C; Jensen JE; Pedersen O; Hansen T; Madsbad S; Holst JJ; Torekov SS
Int J Obes (Lond); 2015 May; 39(5):834-41. PubMed ID: 25287751
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: "GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women" by Iepsen E.W., et al.
Conte C; Cecere A; Guglielmi G; Napoli N
J Clin Endocrinol Metab; 2015 Oct; 100(10):L92-3. PubMed ID: 26439158
[No Abstract] [Full Text] [Related]
5. Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial.
Jensen SBK; Sørensen V; Sandsdal RM; Lehmann EW; Lundgren JR; Juhl CR; Janus C; Ternhamar T; Stallknecht BM; Holst JJ; Jørgensen NR; Jensen JB; Madsbad S; Torekov SS
JAMA Netw Open; 2024 Jun; 7(6):e2416775. PubMed ID: 38916894
[TBL] [Abstract][Full Text] [Related]
6. Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes.
Ariel D; Kim SH; Abbasi F; Lamendola CA; Liu A; Reaven GM
Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):1317-22. PubMed ID: 25280957
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes.
Ottney A
Am J Health Syst Pharm; 2013 Dec; 70(23):2097-103. PubMed ID: 24249759
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
[TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor: Liraglutide-Induced Increase in Bone Formation Can Be Dependent on Osteocalcin.
Kizilgul M; Kan S; Beysel S; Delibasi T
J Clin Endocrinol Metab; 2015 Sep; 100(9):L71. PubMed ID: 26339737
[No Abstract] [Full Text] [Related]
11. GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction.
Pastel E; McCulloch LJ; Ward R; Joshi S; Gooding KM; Shore AC; Kos K
Clin Sci (Lond); 2017 Mar; 131(5):343-353. PubMed ID: 28049736
[TBL] [Abstract][Full Text] [Related]
12. Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhang F; Tong Y; Su N; Li Y; Tang L; Huang L; Tong N
J Diabetes; 2015 May; 7(3):329-39. PubMed ID: 25043423
[TBL] [Abstract][Full Text] [Related]
13. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin.
Jensterle Sever M; Kocjan T; Pfeifer M; Kravos NA; Janez A
Eur J Endocrinol; 2014 Mar; 170(3):451-9. PubMed ID: 24362411
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
[TBL] [Abstract][Full Text] [Related]
15. Diets higher in dairy foods and dietary protein support bone health during diet- and exercise-induced weight loss in overweight and obese premenopausal women.
Josse AR; Atkinson SA; Tarnopolsky MA; Phillips SM
J Clin Endocrinol Metab; 2012 Jan; 97(1):251-60. PubMed ID: 22049177
[TBL] [Abstract][Full Text] [Related]
16. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C
Bone; 2007 Mar; 40(3):723-9. PubMed ID: 17081815
[TBL] [Abstract][Full Text] [Related]
17. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.
Clemmensen C; Finan B; Fischer K; Tom RZ; Legutko B; Sehrer L; Heine D; Grassl N; Meyer CW; Henderson B; Hofmann SM; Tschöp MH; Van der Ploeg LH; Müller TD
EMBO Mol Med; 2015 Mar; 7(3):288-98. PubMed ID: 25652173
[TBL] [Abstract][Full Text] [Related]
18. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF; Mannucci E; Ahrén B
Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
[TBL] [Abstract][Full Text] [Related]
20. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
